We provide you with 20 years of free, institutional-grade data for VCYT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of VCYT. Explore the full financial landscape of VCYT stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-07 | 1384101 | VCYT | 10-Q | Url |
2025-05-08 | 1384101 | VCYT | 10-Q | Url |
2025-02-28 | 1384101 | VCYT | 10-K | Url |
2024-11-07 | 1384101 | VCYT | 10-Q | Url |
2024-08-07 | 1384101 | VCYT | 10-Q | Url |
2024-05-08 | 1384101 | VCYT | 10-Q | Url |
2024-02-29 | 1384101 | VCYT | 10-K | Url |
2023-11-08 | 1384101 | VCYT | 10-Q | Url |
2023-08-09 | 1384101 | VCYT | 10-Q | Url |
2023-05-05 | 1384101 | VCYT | 10-Q | Url |
2023-03-01 | 1384101 | VCYT | 10-K | Url |
2022-11-03 | 1384101 | VCYT | 10-Q | Url |
2022-08-03 | 1384101 | VCYT | 10-Q | Url |
2022-05-04 | 1384101 | VCYT | 10-Q | Url |
2022-02-28 | 1384101 | VCYT | 10-K | Url |
2021-11-09 | 1384101 | VCYT | 10-Q | Url |
2021-07-29 | 1384101 | VCYT | 10-Q | Url |
2021-05-10 | 1384101 | VCYT | 10-Q | Url |
2021-02-22 | 1384101 | VCYT | 10-K | Url |
2020-11-02 | 1384101 | VCYT | 10-Q | Url |
2020-07-30 | 1384101 | VCYT | 10-Q | Url |
2020-05-06 | 1384101 | VCYT | 10-Q | Url |
2020-02-25 | 1384101 | VCYT | 10-K | Url |
2019-10-22 | 1384101 | VCYT | 10-Q | Url |
2019-07-30 | 1384101 | VCYT | 10-Q | Url |
2019-04-30 | 1384101 | VCYT | 10-Q | Url |
2019-02-25 | 1384101 | VCYT | 10-K | Url |
2018-10-29 | 1384101 | VCYT | 10-Q | Url |
2018-07-23 | 1384101 | VCYT | 10-Q | Url |
2018-05-01 | 1384101 | VCYT | 10-Q | Url |
2018-02-27 | 1384101 | VCYT | 10-K | Url |
2017-11-07 | 1384101 | VCYT | 10-Q | Url |
2017-07-31 | 1384101 | VCYT | 10-Q | Url |
2017-05-03 | 1384101 | VCYT | 10-Q | Url |
2017-03-01 | 1384101 | VCYT | 10-K | Url |
2016-11-03 | 1384101 | VCYT | 10-Q | Url |
2016-08-03 | 1384101 | VCYT | 10-Q | Url |
2016-05-05 | 1384101 | VCYT | 10-Q | Url |
2016-03-14 | 1384101 | VCYT | 10-K | Url |
2015-11-05 | 1384101 | VCYT | 10-Q | Url |
2015-08-13 | 1384101 | VCYT | 10-Q | Url |
2015-05-15 | 1384101 | VCYT | 10-Q | Url |
2015-03-25 | 1384101 | VCYT | 10-K | Url |
2014-11-13 | 1384101 | VCYT | 10-Q | Url |
2014-08-14 | 1384101 | VCYT | 10-Q | Url |
2014-05-09 | 1384101 | VCYT | 10-Q | Url |
2014-03-20 | 1384101 | VCYT | 10-K | Url |
2013-11-25 | 1384101 | VCYT | 10-Q | Url |
2013-09-20 | 1384101 | VCYT | S-1 | Url |
Veracyte, Inc(NASDAQ:VCYT)


Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to identify patients with benign thyroid nodules among those with indeterminate cytopathology results in orde...
Website: http://www.veracyte.com
Founded: 2006
Full Time Employees: 354
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about VCYT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.